JPMorgan downgrades this drugmaker, cuts price target by 19% citing growth challenges
Shares of Abbott India Ltd. gained on Wednesday, April 15, even as brokerage firm JPMorgan reduced its rating and cut its target price by 19.11%. JPMorgan has downgraded the stock to ‘neutral’ from ‘overweight’ and has cut its target price to ₹27,500 per share from the previous ₹34,000 apiece. It said the company has a…
